Globe Roche Logo

Roche expands Global Access Program to include the first fully automated CE marked nucleic acid HIV-1/HIV-2 qualitative diagnostic test

Roche announced today the expansion of the Global Access Program to include the cobas® HIV-1/HIV-2 for use on the fully automated cobas® 6800/8800 Systems. The test provides healthcare professionals with the ability to differentiate HIV-1 from HIV-2.

Explore

Roche launches the first fully automated CE marked HIV-1/HIV-2 qualitative diagnostic test on cobas® 6800/8800 Systems

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial availability of the cobas® HIV-1/HIV-2 for use on the automated cobas® 6800/8800 Systems in countries accepting the CE mark.

Explore

Roche HIV Global Access Program expands to include next-generation automated platform solutions

High throughput cobas® systems help optimize workflow for resource-limited settings Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the expansion...

Explore

cobas® HIV-1 for use on the cobas® 4800 System

Confidently and effectively quantify HIV-1 using a dual-target approach with cobas® HIV-1 -for the cobas® 4800 System.

More

COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Qualitative Test

Simple workflow and ready-to-use reagents to support early diagnosis and treatment for improved disease management.

More

COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0

Increase the probability of HIV-1 detection by targeting two highly conserved regions of the HIV-1 genome.

More

COBAS® AmpliScreen HIV-1 Test, v1.5

A polymerase chain reaction (PCR) test for the detection of human immunodeficiency virus type 1 (HIV-1) RNA in human plasma.

More

cobas® HIV-1 for use on the cobas® 6800/8800 System

Detect HIV-1 variants with dual-target confidence and potentially avoid under-quantification.

More

cobas® MPX

Detects and discriminates the most critical viral targets in one easy-to-use assay.

More

COBAS® TaqMan® HIV-1 Test, v2.0 For Use With The High Pure System

An advanced and reliable HIV-1 viral load detection with a dual-target approach

More

cobas® TaqScreen MPX Test

A multiplex, real-time PCR test that detects the presence of human immunodeficiency virus type 1 (HIV-1, groups M and O), human immunodeficiency virus type 2 (HIV-2), hepatitis C virus (HCV) and hepatitis B virus…

More

cobas® TaqScreen MPX Test, v2.0

A multiplex, real-time PCR test that offers immediate virus discrimination of HIV, HCV and HBV in donations of human whole blood and blood components including source plasma.

More

Roche receives FDA approval for HIV-1 viral load test on the cobas® 6800/8800 Systems

HIV-1 test expands menu for highly automated molecular platforms that offer fastest time to results.

Explore

Roche expands cobas® 4800 System menu with HIV-1, HCV and HCV Genotyping Tests

System portfolio broadens to include high medical value virology assays

Explore

Roche expands HIV Global Access Program to include infants in resource limited settings

Program adds early infant testing to further support the  90:90:90 UNAIDS goal

Explore

Roche to provide HIV diagnostic solutions to Global Fund

Framework agreement with Global Fund strengthens access to HIV diagnostics

Explore

Roche launches next-generation duplex test for parvovirus B19 and hepatitis A in markets accepting the CE mark

Cobas® DPX assay increases safety of human plasma and plasma products

Explore

Roche launches next-generation viral load testing assays for new molecular diagnostic platforms in markets accepting the CE mark

cobas HIV-1 and HCV assays offer unparalleled performance on cobas 6800/8800 Systems.

Explore

Roche launches Global Access Program for HIV viral load testing

Program expands access to care supporting the Diagnostics Access Initiative.

Explore

Roche provides HIV diagnostic update at 2014 International AIDS Conference

Novel solutions contribute towards scale up efforts for HIV diagnosis and monitoring

Explore

Roche announces launch of the Dual Target HIV-1 Qualitative Test in markets accepting the CE mark

New test will help increase access for early infant HIV diagnosis.

Explore

Roche announces FDA approval of HIV viral load test

Test is based on innovative dual-target approach

Explore

New Roche screening test for abacavir hypersensitivity available in Europe

The test confidently detects HLA-B*5701 to help decrease risk of abacavir hypersensitivity reaction

Explore

Blood Screening Test That Offers Immediate Viral Discrimination for Three Major Viruses Receives CE Mark

cobas® TaqScreen MPX Test, v2.0[1] provides real-time results for HIV, HCV and HBV

Explore

Roche expands use of novel HIV test

Test with enhanced reliability for monitoring HIV patients now CE marked

Explore

FDA Approves New Roche Dual-PCR Target HIV-1 Test

First dual-PCR target viral load test approved for monitoring HIV patients receiving antiretroviral therapy

Explore

FDA approves use of Roche test to screen source plasma for HIV, hepatitis B virus and hepatitis C virus

cobas® TaqScreen MPX Test is the most comprehensive - detects multiple viruses for increased plasma product safety

Explore

Roche introduces new cobas p 630 Instrument and AMPLILINK 3.3 Series Software with CE Mark

New pre-analytical solution that integrates automated primary tube handling

Explore

FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B &amp, Hepatitis C

Advanced test for increased blood safety is first to add the detection of HIV-1 Group O RNA and HIV-2 RNA

Explore

New Roche Dual Target HIV-1 Test Approved for Use in European Union

Extra confidence and security with an innovative Roche solution

Explore

Highly sensitive and accurate Roche HIV-1 Test approved by FDA

Automated test enables faster results for doctors monitoring treatment response Roche announced today that the U.S. Food & Drug Administration (FDA) has approved its new HIV-1 test for diagnostic use in the United States. The highly accurate Cobas AmpliPrep/Cobas TaqMan …

Explore

FDA Accepts for Review New Roche Diagnostics Blood Screening Test

Automated test is designed to detect broader range of HIV and hepatitis in a single multiplex assay. Roche Diagnostics announced today that the United States (U.S.) Food & Drug Administration has accepted for review its application for a new test …

Explore